Abbott Laboratories

Announced: 10/19/11Chairman and CEO Miles White (left) spent years buying up businesses to build a healthcare heavyweight, and now he's breaking it up. Abbott Labs will retain its diversified medical products business -- everything from branded generics to diagnostics and devices -- while spinning off its costlier pharma R&D unit that has a heavy revenue concentration in developed markets.